Transplantační medicína

Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

Think Fabry, think timely testing first.

Think Fabry, think timely testing first.

Think Fabry, think timely testing first.

Think Fabry, think timely testing first.

Think Fabry, think timely testing first.

Think Fabry, think regular profile-based assessments.

Think Fabry, think regular profile-based assessments.

Think Fabry, think regular profile-based assessments.

Think Fabry, think regular profile-based assessments.

Think Fabry, think regular profile-based assessments.

Cardiovascular disease is the leading cause of death in Fabry disease patients.¹ Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.^2,3